Significantly, AMP-depleted tumour-derived cells obtained after BT-474 injection into mice showed a reduction in NANOG, OCT4 and BMI1 gene expression, providing evidence that AMPK can also drive transcriptional upregulation and maintenance of stemness markers in the in vivo tumour microenvironment (Fig. S2G). Here, BMI1 is linked to neoplasm.